Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzamide, heteroarylamide and reverse amides

Benzamide, heteroarylamide and reverse amides

US Patent 7214677 · Granted May 8, 2007

Estimated economic value: $277,542,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Calicheamicin derivatives and antibody drug conjugates thereof2024
Inhibitors for coronavirus2024
Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike r2024
Anti-EDB antibodies and antibody-drug conjugates2023
Bifunctional cytotoxic agents containing the CTI pharmacophore2022
Bifunctional cytotoxic agents containing the CTI pharmacophore2020
Tubulysin analogs and methods for their preparation2020
Bifunctional cytotoxic agents2019
Bifunctional cytotoxic agents2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018